{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:56:17Z","timestamp":1790715377204,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903722"],"award-info":[{"award-number":["81903722"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2023YFS0047"],"award-info":[{"award-number":["2023YFS0047"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017501","name":"Science-Health Joint Medical Scientific Research Project of Chongqing","doi-asserted-by":"publisher","award":["2023MSXM068"],"award-info":[{"award-number":["2023MSXM068"]}],"id":[{"id":"10.13039\/100017501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.heliyon.2024.e26132","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T03:45:24Z","timestamp":1707450324000},"page":"e26132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Quantification of meropenem in serum and cerebrospinal fluid in children with bacterial meningitis with augmented renal clearance by UPLC\u2013MS\/MS"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4934-7350","authenticated-orcid":false,"given":"Ying","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9375-6664","authenticated-orcid":false,"given":"Mengyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjie","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiyao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8789-4219","authenticated-orcid":false,"given":"Zhenlei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e26132_bib1","unstructured":"Insert package. AstraZeneca Pharmaceuticals, LP. Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/050706s041lbl.pdf."},{"key":"10.1016\/j.heliyon.2024.e26132_bib2","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/cid\/ciw861","article-title":"Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis","volume":"64","author":"Tunkel","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e26132_bib3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrneph.2011.92","article-title":"Implications of augmented renal clearance in critically ill patients","volume":"7","author":"Udy","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.heliyon.2024.e26132_bib4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/FTD.0000000000000270","article-title":"Augmented renal clearance in pediatric patients with febrile neutropenia associated with vancomycin clearance","volume":"38","author":"Hirai","year":"2016","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.heliyon.2024.e26132_bib5","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00228-022-03291-5","article-title":"Investigation of pharmacokinetic and clinical outcomes of various meropenem regimens in patients with ventilator-associated pneumonia and augmented renal clearance","volume":"78","author":"Razzazzadeh","year":"2022","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e26132_bib6","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jiac.2018.07.007","article-title":"The exploration of population pharmacokinetic model for meropenem in augmented renal clearance and investigation of optimum setting of dose","volume":"24","author":"Tamatsukuri","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.heliyon.2024.e26132_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.728075","article-title":"Case report: subtherapeutic vancomycin and meropenem concentrations due to augmented renal clearance in a patient with intracranial infection caused by Streptococcus intermedius","volume":"12","author":"Fransson","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e26132_bib8","article-title":"Risk factors associated with prolonged antibiotic use in pediatric bacterial meningitis","volume":"13","author":"He","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e26132_bib9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijantimicag.2019.06.021","article-title":"Cerebrospinal pharmacokinetic and pharmacodynamic analysis of efficacy of meropenem in paediatric patients with bacterial meningitis","volume":"54","author":"Ohata","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.heliyon.2024.e26132_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113289","article-title":"HILIC LC-MS\/MS method for the quantification of cefepime, imipenem and meropenem","volume":"186","author":"Rehm","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2024.e26132_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/FTD.0000000000000570","article-title":"Simultaneous quantification of nine antimicrobials by LC-MS\/MS for therapeutic drug monitoring in critically ill patients","volume":"41","author":"Neugebauer","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.heliyon.2024.e26132_bib12","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/jalm\/jfab036","article-title":"Stability and validation of a high-throughput LC-MS\/MS method for the quantification of cefepime, meropenem, and piperacillin and tazobactam in serum","volume":"6","author":"Bjergum","year":"2021","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.heliyon.2024.e26132_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.113944","article-title":"An isotope-dilution LC-MS\/MS method for the simultaneous quantification of meropenem and its open-ring metabolite in serum","volume":"197","author":"Rakete","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2024.e26132_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jpba.2019.02.037","article-title":"LC-MS\/MS method for simultaneous determination of linezolid, meropenem, piperacillin and teicoplanin in human plasma samples","volume":"169","author":"Ferrari","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2024.e26132_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5185","article-title":"Simultaneous determination of meropenem and imipenem in rat plasma by LC-MS\/MS and its application to a pharmacokinetic study","volume":"35","author":"Peng","year":"2021","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.heliyon.2024.e26132_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5377","article-title":"Simultaneous determination of novel \u03b2-lactamase inhibitor WCK 4234 and Meropenem in dog plasma by LC-MS\/MS and its application to preclinical pharmacokinetic study","volume":"36","author":"Patil","year":"2022","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.heliyon.2024.e26132_bib17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4155\/bio-2016-0157","article-title":"Simultaneous assay of multiple antibiotics in human plasma by LC-MS\/MS: importance of optimizing formic acid concentration","volume":"9","author":"Chen","year":"2017","journal-title":"Bioanalysis"},{"key":"10.1016\/j.heliyon.2024.e26132_bib18","article-title":"Quantification of cefepime, meropenem, piperacillin, and tazobactam in human plasma using a sensitive and robust liquid chromatography-tandem mass spectrometry method, Part 1: assay development and validation","volume":"62","author":"D'Cunha","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.heliyon.2024.e26132_bib19","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1515\/cclm-2014-0746","article-title":"Quantification of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in serum using an isotope dilution UHPLC-MS\/MS method with semi-automated sample preparation","volume":"53","author":"Zander","year":"2015","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.heliyon.2024.e26132_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jac\/34.1.175","article-title":"Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges","volume":"34","author":"Dagan","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.heliyon.2024.e26132_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.talanta.2008.06.045","article-title":"Stability-indicating determination of meropenem in presence of its degradation product","volume":"77","author":"Elragehy","year":"2008","journal-title":"TALANTA"},{"key":"10.1016\/j.heliyon.2024.e26132_bib25","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.saa.2008.12.025","article-title":"Selective determination of ertapenem in the presence of its degradation product","volume":"72","author":"Hassan","year":"2009","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.heliyon.2024.e26132_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/AAC.26.1.78","article-title":"Determination of imipenem and cilastatin in serum by high-pressure liquid chromatography","volume":"26","author":"Myers","year":"1984","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.heliyon.2024.e26132_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0731-7085(90)80038-Q","article-title":"Determination of imipenem in human plasma, urine and tissue by high-performance liquid chromatography","volume":"8","author":"Carlucci","year":"1990","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2024.e26132_bib28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jchromb.2008.09.020","article-title":"Simultaneous determination of three carbapenem antibiotics in plasma by HPLC with ultraviolet detection","volume":"875","author":"Legrand","year":"2008","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.heliyon.2024.e26132_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jchromb.2007.10.041","article-title":"Simultaneous determination of cefepime, vancomycin and imipenem in human plasma of burn patients by high-performance liquid chromatography","volume":"860","author":"L\u00f3pez","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.heliyon.2024.e26132_bib30","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jchromb.2011.03.038","article-title":"A liquid chromatography assay for a quantification of doripenem, ertapenem, imipenem, meropenem concentrations in human plasma: application to a clinical pharmacokinetic study","volume":"879","author":"Dailly","year":"2011","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.heliyon.2024.e26132_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0378-4347(84)80069-9","article-title":"Determination of imipenem (N-formimidoyl thienamycin) in human plasma and urine by high-performance liquid chromatography, comparison with microbiological methodology and stability","volume":"310","author":"Gravallese","year":"1984","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.heliyon.2024.e26132_bib32","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 13.1, 2023. http:\/\/www.eucast.org\/."},{"key":"10.1016\/j.heliyon.2024.e26132_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e26132_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2165\/00003088-199528040-00002","article-title":"Meropenem clinical pharmacokinetics","volume":"28","author":"Mouton","year":"1995","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.heliyon.2024.e26132_bib35","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijantimicag.2012.05.010","article-title":"Decreased meropenem levels in Intensive Care Unit patients with augmented renal clearance: benefit of therapeutic drug monitoring","volume":"40","author":"Tr\u00f6ger","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.heliyon.2024.e26132_bib36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ijantimicag.2017.11.013","article-title":"Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of \u03b2-lactams administered by continuous infusion: a prospective observational study","volume":"51","author":"Carri\u00e9","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.heliyon.2024.e26132_bib37","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1128\/AAC.01725-09","article-title":"Brain microdialysis study of meropenem in two patients with acute brain injury","volume":"54","author":"Dahyot-Fizelier","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.heliyon.2024.e26132_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007117","article-title":"Development of a physiologically-based pharmacokinetic pediatric brain model for prediction of cerebrospinal fluid drug concentrations and the influence of meningitis","volume":"15","author":"Verscheijden","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.heliyon.2024.e26132_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11318140-000000000-00000","article-title":"Augmented renal clearance: implications for antibacterial dosing in the critically ill","volume":"49","author":"Udy","year":"2010","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.heliyon.2024.e26132_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00228-019-02761-7","article-title":"Population pharmacokinetics of meropenem in critically ill children with different renal functions","volume":"76","author":"Rapp","year":"2020","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024021637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024021637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:57:19Z","timestamp":1790711839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024021637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2405844024021637"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26132","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of meropenem in serum and cerebrospinal fluid in children with bacterial meningitis with augmented renal clearance by UPLC\u2013MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e26132"}}